Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study. Swiss Medical Weekly, [S. l.], v. 153, n. 6, p. 40090, 2023. DOI: 10.57187/smw.2023.40090. Disponível em: https://www.smw.ch/index.php/smw/article/view/3346. Acesso em: 29 oct. 2025.